News

Apr232021

What are patients’ needs and how to improve the development of medicines?

What are patients’ needs and how to improve the development of medicines? First c4c Multi-Stakeholder Meeting on paediatric Inflammatory Bowel Disease (IBD). c4c held its first International Multi-Stakeholder Meeting (MSM) on paediatric Inflammatory Bowel Disease (IBD) virtually on 14-15 April 2021. Over 100 individuals participated, representing patients and advocates, clinicians, academics, pharmaceutical companies and regulators.…

Details

Empowering trial staff one course at a time – 2021 Invitation to Join

In c4c, we are creating an integrated educational program, developed jointly by academia and industry companies, to address best practice in paediatric clinical trials and paediatric medicine development. So far, 31 courses have been developed within our consortium in the fields of: Good Clinical Practice (GCP basic courses) Competence Development courses in Good Clinical Practice…

Details

Mar312021

Mar222021

The role of PPI (patient public involvement) within clinical trials in c4c

The voice of the patient in clinical research and development is increasingly being taken into account, from the setting of research priorities right through to dissemination of results. This marks a shift in what has historically and culturally been seen, until relatively recently, as research “on” rather than “with” patients. PPI is an inherent part…

Details

Paediatric clinical trials: industry and non-industry coming together within c4c

Clinical trials are an essential part of advancing knowledge and improving healthcare worldwide. Advances in paediatric research across the globe to improve the lives of babies, children and young people have dramatically reduced rates in morbidity and mortality and increased the quality of life, for example, reducing sudden infant death, increasing the life expectancy for…

Details

Mar222021

Mar42021

National Hub meeting outcomes

c4c held the first workshop on Young Persons Advocacy Groups (YPAG) for the PPI liaisons in the National Hubs on the 28 January and 4 February held over ZOOM virtual meeting platform. In case you are not familiar with this term, A Young Persons Advisory Group (YPAG) is a group made up of children and…

Details

Subscribe to our newsletter to keep up to date with all C4C news

What are patients’ needs and how to improve the development of medicines?

Empowering trial staff one course at a time – 2021 Invitation to Join

The role of PPI (patient public involvement) within clinical trials in c4c

Paediatric clinical trials: industry and non-industry coming together within c4c

National Hub meeting outcomes